Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Be Brave-A Networking Tale that Led to Friendship
Summary
In this episode, Josh Yoder and Kirsten Borbe to share their amazing story of how a networking message on LinkedIn led to a friendship. The discussion begins with insights into Josh and Kirsten's backgrounds and networking perspectives. They emphasize the importance of authentic networking and overcoming fear, sharing strategies for building genuine connections and evolving professional relationships into friendships. Key communication skills such as brevity and authenticity are highlighted, alongside the role of altruism in networking. The conversation addresses the fear of risk and concludes with thoughts on networking courage and bravery. Closing remarks offer appreciation for the insights shared.
Key Points
- Networking should be approached with authenticity and a genuine interest in others, rather than self-promotion.
- Building meaningful connections often involves taking risks and embracing opportunities, even if it means stepping out of your comfort zone.
- The real value in networking comes from helping others without expecting anything in return, which often leads to more fulfilling and long-lasting relationships.
authentic networking, LinkedIn connections, overcoming networking fear, building genuine connections, networking communication skills, altruism in networking, networking courage
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD